Drug firms 'bury' poor trial results on antidepressants

The issue of the current class of anti-depressants has been linked for years to many problems. I have been alerting the public and other health professionals to this risk for a decade at least.

I guess enough money has come in from duped doctors and patients to allow press coverage...

By Nina Lakhani Published: 20 January 2008
Drug companies are placing depressed patients at risk by not publishing negative results from clinical trials and distorting the evidence doctors use to decide which drugs to prescribe.

New research published in The New England Journal of Medicine found nearly a third of the 74 industry-sponsored studies of antidepressants they examined were not published, most of which showed negative outcomes for the drug involved. Not only were positive results 12 times more likely to be published, but negative results were often written so as to convey a favourable outcome.

Researchers warn that selective reporting of clinical trials can lead to misrepresentation of the benefits and risks of a drug and could mislead healthcare professionals into believing some drugs are more effective and less harmful than they actually are, which could place patients at risk.

The published articles suggest 94 per cent of the trials conducted had positive results, whereas analysis by the FDA found only half were favourable.
http://news.independent.co.uk/health/article3353758.ece

For natural help please contact us or refer to http://www.leaflady.org/natural_mental_health.htm